GHRH analogue research

Tesamorelin

Stabilised GHRH analogue studied in receptor pharmacology and endocrine-axis models.

Explore presentation-specific analytical records covering identity, purity, measured content, lot traceability and downloadable Certificates of Analysis.

Certified presentations
Product information
Royal Pharma Tesamorelin vial
Selected record10 mg

Product-family image supplied by Royal Pharma. Certified presentations are identified by their individual COA records below.

Product authentication

Authenticity, built into every product.

Powered by NFC. Secured by blockchain. Verified instantly.

Each Royal Pharma product carries a unique NFC-enabled microchip connected to the brand's proprietary blockchain authentication environment, creating a secure, traceable and tamper-resistant digital identity.

01
Unique identity

A product-linked NFC identity designed for one-tap verification.

02
Secure verification

A blockchain-secured record supporting authenticity and traceability.

03
Batch documentation

Presentation-specific COAs document identity, purity, measured content and lot information.

Product information

GHRH analogue research, documented by batch.

Tesamorelin is a stabilised analogue of human growth hormone-releasing hormone used in receptor-pharmacology and endocrine-axis research. The Royal Pharma 10 mg presentation is linked to its sample-specific analytical certificate below.

01

Research class

Stabilised GHRH(1-44) receptor agonist
02

Documentation status

Research reference compound
03

Reference CAS

218949-48-5
04

Physical form

White crystallised powder

Research profile

A full-length GHRH analogue with stabilised signalling.

Tesamorelin is designed for resistance to DPP-4 breakdown while retaining GHRH-receptor activity. Its clinical literature is distinct from the research-only status of the supplied sample.

44 AA
GHRH receptor

The analogue is studied for activity at the growth hormone-releasing hormone receptor.

GHRH
DPP-4 resistance

Sequence modification supports greater enzymatic stability than native GHRH.

DPP-4
Endocrine-axis models

Research examines downstream GH and IGF-1 signalling in controlled settings.

Quality documentation

Certificate of Analysis

Choose a presentation to display the exact analytical record
supplied for that sample.

Select presentation
Selected COA

Tesamorelin · 10 mg

Purity99.73%
Measured content
10.15 mg
Identity
Tesamorelin
Lot
N/A
Appearance
White Crystalized Powder
Accession number
2607085916
Search code
Received
04/07/2026
Reported
4/08/2026
For laboratory research use only.

The supplied certificates state that the tested materials are intended for research use only and are not approved for human or veterinary use, diagnostic, therapeutic or clinical applications. Results are specific to the submitted samples. This page does not provide medical advice, dosing or administration instructions.